The miRNA-mRNA interactome of murine induced pluripotent stem cell-derived chondrocytes in response to inflammatory cytokines

• Published in: The FASEB journal Vol. 34; no. 9; p. 11546
• Main Authors: Ross, Alison K, Coutinho de Almeida, Rodrigo, Ramos, Yolande F M, Li, Jiehan, Meulenbelt, Ingrid, Guilak, Farshid
• Format: Journal Article
• Language: English
• Published: United States 01.09.2020
• Subjects: Animals; Cartilage, Articular - cytology; Cartilage, Articular - drug effects; Cartilage, Articular - metabolism; Cells, Cultured; Chondrocytes - cytology; Chondrocytes - drug effects; Chondrocytes - metabolism; Cytokines - pharmacology; Gene Expression Regulation - drug effects; Gene Regulatory Networks - drug effects; Gene Regulatory Networks - genetics; Humans; Induced Pluripotent Stem Cells - cytology; Induced Pluripotent Stem Cells - metabolism; Inflammation Mediators - pharmacology; Interleukin-1beta - pharmacology; Mice, Inbred C57BL; MicroRNAs - genetics; MicroRNAs - metabolism; RNA, Messenger - genetics; RNA, Messenger - metabolism; Tissue Engineering - methods; Transcriptome - drug effects; Transcriptome - genetics; Tumor Necrosis Factor-alpha - pharmacology; RNA-sequencing; microRNA; tissue engineering; induced pluripotent stem cell; inflammation
• ISSN: 1530-6860
• DOI: 10.1096/fj.202000889R

Osteoarthritis (OA) is a degenerative joint disease, and inflammation within an arthritic joint plays a critical role in disease progression. Pro-inflammatory cytokines, specifically IL-1 and TNF-α, induce aberrant expression of catabolic and degradative enzymes and inflammatory cytokines in OA and result in a challenging environment for cartilage repair and regeneration. MicroRNAs (miRNAS) are small noncoding RNAs and are important regulatory molecules that act by binding to target messenger RNAs (mRNAs) to reduce protein synthesis and have been implicated in many diseases, including OA. The goal of this study was to understand the mechanisms of miRNA regulation of the transcriptome of tissue-engineered cartilage in response to IL-1β and TNF-α using an in vitro murine induced pluripotent stem cell (miPSC) model system. We performed miRNA and mRNA sequencing to determine the temporal and dynamic responses of genes to specific inflammatory cytokines as well as miRNAs that are differentially expressed (DE) in response to both cytokines or exclusively to IL-1β or TNF-α. Through integration of mRNA and miRNA sequencing data, we created networks of miRNA-mRNA interactions which may be controlling the response to inflammatory cytokines. Within the networks, hub miRNAs, miR-29b-3p, miR-17-5p, and miR-20a-5p, were identified. As validation of these findings, we found that delivery of miR-17-5p and miR-20a-5p mimics significantly decreased degradative enzyme activity levels while also decreasing expression of inflammation-related genes in cytokine-treated cells. This study utilized an integrative approach to determine the miRNA interactome controlling the response to inflammatory cytokines and novel mediators of inflammation-driven degradation in tissue-engineered cartilage.